IQVIA™, The Human Data Science Company

Formed through the merger of IMS Health and Quintiles, IQVIA™ is a leading global provider of information, innovative technology solutions and contract research services dedicated to using analytics and science to help healthcare stakeholders find better solutions for their patients. Solutions are powered by the IQVIA CORE™, which combines big data, advanced technology, analytics and extensive industry knowledge.

This is the website for IMS-legacy solutions and capabilities available to the Canadian pharmaceutical market.

Business Applications
Market Insights Learn more »	Technology & Applications Learn more »
Commercial Effectiveness Services Learn more »	Health Access & Outcomes Learn more »

Find out how our team can help.

Latest News

REGISTER TODAY FOR PMPRB FUNDAMENTALS

Change is on the horizon at the PMPRB. Learn about the Board’s role in pricing and gain a broad understanding of PMPRB policies in this detailed, day-long session. Register now for the seminar coming up on Sept. 25 in Montreal or Sept. 26 in Toronto. Or check out our PMPRB Seminars page to learn more about available training.

5 CRITICAL STEPS TO MEET TRANSPARENCY REQUIREMENTS

Canada is following global trends in compliance and, last year, Ontario passed the Health Sector Payment Transparency Act. Check out the key steps that pharma, biotech and medical device companies need to take in order to prepare for reporting requirements.

Key Factors in Launch Excellence: A Powerful and Pertinent Value Proposition

Our latest article in in Canadian Pharmaceutical Marketing looks at the importance of a strong value proposition as a success factor in the unique context of the Canadian market. Read more here.

Transparency Readiness Roadmap Q&A

We received great response to our March 21 webinar on the new Ontario Health Sector Payments Transparency Act 2017. This Q&A document compiles all of the questions raised at the end of the presentation and our responses.

2018 and Beyond: Outlook and Turning Points

The latest report from the IQVIA Institute unveils 10 predictions for 2018 and beyond, including the types of medicines that will be developed, the way technology will contribute to health and how the value of health will be calculated. Read the report.

Driving Precision Performance

Evolving trends and varying environments are generating unprecedented complexities in pharmaceutical markets. This report looks at optimizing performance by knowing the right markets, right influences, right connections and right patients. Read the report.

Chrisoula Nikidis Joins IQVIA as Canadian Head of Compliance and Ethics Solutions

IQVIA is pleased to announce that Chrisoula Nikidis joins us in February 2018 as the new lead of our Canadian Compliance team. Read more here.

More News »